| 2026-04-30 |
财报披露：
美东时间 2026-04-30 盘前发布财报
|
| 2026-02-27 |
详情>>
内部人交易：
Greene Michelle D.共交易2笔
|
| 2026-02-05 |
详情>>
股本变动：
变动后总股本23531.60万股
|
| 2026-02-05 |
详情>>
业绩披露：
2026年中报每股收益3.87美元,归母净利润9.17亿美元,同比去年增长12.38%
|
| 2025-10-30 |
详情>>
业绩披露：
2026年一季报每股收益1.89美元,归母净利润4.50亿美元,同比去年增长8.17%
|
| 2025-09-16 |
股东大会：
将于2025-11-05召开股东大会
会议内容 ▼▲
- 1.Elect the 12 director nominees named in the proxy statement;
2.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
3.Ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2026;
4.Transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2025-08-12 |
详情>>
业绩披露：
2025年年报每股收益6.48美元,归母净利润15.61亿美元,同比去年增长83.22%
|
| 2025-08-12 |
详情>>
业绩披露：
2023年年报每股收益1.27美元,归母净利润3.30亿美元,同比去年增长135.18%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年三季报(累计)每股收益5.47美元,归母净利润13.22亿美元,同比去年增长114.61%
|
| 2025-01-30 |
详情>>
业绩披露：
2025年中报每股收益3.37美元,归母净利润8.16亿美元,同比去年增长127.93%
|
| 2024-11-01 |
详情>>
业绩披露：
2024年一季报每股收益-0.05美元,归母净利润-1200万美元,同比去年增长-110.91%
|
| 2024-11-01 |
详情>>
业绩披露：
2025年一季报每股收益1.71美元,归母净利润4.16亿美元,同比去年增长3566.67%
|
| 2024-09-16 |
股东大会：
将于2024-11-06召开股东大会
会议内容 ▼▲
- 1.Elect the 10 director nominees named in the proxy statement;
2.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
3.Ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2025;
4.Vote on a shareholder proposal described in the proxy statement, if properly presented at the Annual Meeting;
5.Transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年年报每股收益3.48美元,归母净利润8.52亿美元,同比去年增长158.18%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年三季报(累计)每股收益2.51美元,归母净利润6.16亿美元,同比去年增长89.54%
|
| 2024-02-01 |
详情>>
业绩披露：
2024年中报每股收益1.45美元,归母净利润3.58亿美元,同比去年增长1890.00%
|
| 2023-09-27 |
股东大会：
将于2023-11-15召开股东大会
会议内容 ▼▲
- 1.Elect the 11 director nominees named in the proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2024;
3.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve the compensation of our named executive officers;
5.Vote on two shareholder proposals described in the proxy statement, if properly presented at the Annual Meeting;
6.Transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2022-09-28 |
股东大会：
将于2022-11-09召开股东大会
会议内容 ▼▲
- 1.Elect the 13 director nominees named in the proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2023;
3.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2021-09-23 |
股东大会：
将于2021-11-05召开股东大会
会议内容 ▼▲
- 1.Elect the 11 director nominees named in the proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2022;
3.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.Approve the Cardinal Health, Inc. 2021 Long-Term Incentive Plan;
5.Approve an amendment to our Restated Code of Regulations to reduce the share ownership threshold for calling a special meeting of shareholders;
6.Vote on a shareholder proposal described in the accompanying proxy statement, if properly presented at the meeting;
7.Transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-09-23 |
股东大会：
将于2020-11-04召开股东大会
会议内容 ▼▲
- 1.Elect the 13 director nominees named in the proxy statement;
2.Ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2021;
3.Approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.Approve an amendment to our Restated Code of Regulations to reduce the share ownership threshold for calling a special meeting of shareholders;
5.Vote on two shareholder proposals described in the accompanying proxy statement, if properly presented at the meeting;
6.Transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2020-02-11 |
除权日：
美东时间 2020-03-31 每股派息0.48美元
|
| 2019-11-07 |
除权日：
美东时间 2019-12-31 每股派息0.48美元
|
| 2019-09-20 |
股东大会：
将于2019-11-06召开股东大会
会议内容 ▼▲
- 1.To elect the 12 director nominees named in the proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2020;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2019-08-08 |
除权日：
美东时间 2019-09-30 每股派息0.48美元
|
| 2019-05-08 |
除权日：
美东时间 2019-06-28 每股派息0.48美元
|
| 2019-02-07 |
除权日：
美东时间 2019-03-29 每股派息0.48美元
|
| 2018-11-07 |
除权日：
美东时间 2018-12-31 每股派息0.48美元
|
| 2018-09-26 |
股东大会：
将于2018-11-07召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees named in the proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2019;
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers;
4.To vote on two shareholder proposals described in the accompanying proxy statement, if properly presented at the meeting;
5.To transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2018-08-08 |
除权日：
美东时间 2018-09-28 每股派息0.48美元
|
| 2018-05-09 |
除权日：
美东时间 2018-06-29 每股派息0.48美元
|
| 2018-02-07 |
除权日：
美东时间 2018-03-29 每股派息0.46美元
|
| 2017-11-08 |
除权日：
美东时间 2017-12-29 每股派息0.46美元
|
| 2017-09-21 |
股东大会：
将于2017-11-08召开股东大会
会议内容 ▼▲
- (1)To elect the 11 director nominees named in the proxy statement;
(2)To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2018;
(3)To approve, on a non-binding advisory basis, the compensation of our named executive officers;
(4)To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve executive compensation;
(5)To vote on two shareholder proposals described in the accompanying proxy statement, if properly presented at the meeting;
(6)To transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2017-08-10 |
除权日：
美东时间 2017-09-29 每股派息0.46美元
|
| 2017-05-03 |
除权日：
美东时间 2017-06-29 每股派息0.46美元
|
| 2017-02-02 |
除权日：
美东时间 2017-03-30 每股派息0.45美元
|
| 2016-11-03 |
除权日：
美东时间 2016-12-29 每股派息0.45美元
|
| 2016-09-16 |
股东大会：
将于2016-11-03召开股东大会
会议内容 ▼▲
- (1)To elect the 11 director nominees named in the proxy statement;
(2)To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2017;
(3)To approve the Amended Cardinal Health, Inc. 2011 Long-Term Incentive Plan;
(4)To approve, on a non-binding advisory basis, the compensation of our named executive officers;
(5)To transact such other business as may properly come before the meeting or any adjournment or postponement.
|
| 2016-08-08 |
除权日：
美东时间 2016-09-29 每股派息0.45美元
|
| 2016-05-04 |
除权日：
美东时间 2016-06-29 每股派息0.45美元
|
| 2016-02-02 |
除权日：
美东时间 2016-03-30 每股派息0.39美元
|
| 2015-11-04 |
除权日：
美东时间 2015-12-30 每股派息0.39美元
|
| 2015-08-05 |
除权日：
美东时间 2015-09-29 每股派息0.39美元
|
| 2015-05-06 |
除权日：
美东时间 2015-06-29 每股派息0.39美元
|
| 2015-02-03 |
除权日：
美东时间 2015-03-30 每股派息0.34美元
|
| 2014-11-05 |
除权日：
美东时间 2014-12-30 每股派息0.34美元
|
| 2014-08-06 |
除权日：
美东时间 2014-09-29 每股派息0.34美元
|
| 2014-05-07 |
除权日：
美东时间 2014-06-27 每股派息0.34美元
|
| 2014-02-05 |
除权日：
美东时间 2014-03-28 每股派息0.30美元
|
| 2013-12-11 |
复牌提示：
2013-12-10 10:57:42 停牌，复牌日期 2013-12-10 11:08:17
|
| 2013-11-06 |
除权日：
美东时间 2013-12-30 每股派息0.30美元
|
| 2013-08-07 |
除权日：
美东时间 2013-09-27 每股派息0.30美元
|
| 2013-05-02 |
除权日：
美东时间 2013-06-27 每股派息0.30美元
|
| 2013-02-06 |
除权日：
美东时间 2013-03-27 每股派息0.28美元
|
| 2012-10-30 |
除权日：
美东时间 2012-12-28 每股派息0.28美元
|
| 2012-08-08 |
除权日：
美东时间 2012-09-27 每股派息0.24美元
|
| 2012-05-02 |
除权日：
美东时间 2012-06-27 每股派息0.24美元
|
| 2012-02-08 |
除权日：
美东时间 2012-03-28 每股派息0.22美元
|
| 2011-11-02 |
除权日：
美东时间 2011-12-28 每股派息0.22美元
|
| 2011-08-03 |
除权日：
美东时间 2011-09-28 每股派息0.22美元
|
| 2011-05-04 |
除权日：
美东时间 2011-06-29 每股派息0.22美元
|
| 2011-02-01 |
除权日：
美东时间 2011-03-30 每股派息0.20美元
|
| 2010-11-03 |
除权日：
美东时间 2010-12-29 每股派息0.20美元
|
| 2010-08-04 |
除权日：
美东时间 2010-09-29 每股派息0.20美元
|
| 2010-05-05 |
除权日：
美东时间 2010-06-29 每股派息0.20美元
|